Improving Diversity in Clinical Trials by Using Real-world Data to Define Eligibility Criteria

被引：7
|
作者：
Royce, Trevor J. [1 ,2 ,3 ]
Zhao, Yihua [1 ]
Ryals, Cleo A. [1 ]
机构：
[1] Flatiron Hlth Inc, New York, NY USA
[2] Wake Forest Univ, Dept Radiat Oncol, Sch Med, Winston Salem, NC USA
[3] Flatiron Hlth Inc, 233 Spring St, New York, NY 10013 USA
来源：
JAMA ONCOLOGY | 2023年 / 9卷 / 04期
关键词：
D O I：
10.1001/jamaoncol.2022.7170
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This Viewpoint discusses the need for thoughtful, modernized eligibility criteria with equity prioritization in clinical trials.
引用
下载
收藏
页码：455 / 456
页数：2
相关论文
共 50 条
  • [1] Evaluating eligibility criteria of oncology trials using real-world data and AI
    Liu, Ruishan
    Rizzo, Shemra
    Whipple, Samuel
    Pal, Navdeep
    Pineda, Arturo Lopez
    Lu, Michael
    Arnieri, Brandon
    Lu, Ying
    Capra, William
    Copping, Ryan
    Zou, James
    NATURE, 2021, 592 (7855) : 629 - +
  • [2] Evaluating eligibility criteria of oncology trials using real-world data and AI
    Ruishan Liu
    Shemra Rizzo
    Samuel Whipple
    Navdeep Pal
    Arturo Lopez Pineda
    Michael Lu
    Brandon Arnieri
    Ying Lu
    William Capra
    Ryan Copping
    James Zou
    Nature, 2021, 592 : 629 - 633
  • [3] Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
    Scott R. Evans
    Dianne Paraoan
    Jane Perlmutter
    Sudha R. Raman
    John J. Sheehan
    Zachary P. Hallinan
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 545 - 552
  • [4] Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials
    Melzer, Georg
    Maiwald, Tim
    Prokosch, Hans-Ulrich
    Ganslandt, Thomas
    APPLIED CLINICAL INFORMATICS, 2021, 12 (01): : 17 - 26
  • [5] Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
    Evans, Scott R.
    Paraoan, Dianne
    Perlmutter, Jane
    Raman, Sudha R.
    Sheehan, John J.
    Hallinan, Zachary P.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (03) : 545 - 552
  • [6] Eligibility of real-world patients with metastatic breast cancer for clinical trials
    Batra, Atul
    Kong, Shiying
    Cheung, Winson Y.
    BREAST, 2020, 54 : 171 - 178
  • [7] Eligibility of real-world patients with metastatic breast cancer in clinical trials
    Batra, A.
    Kong, S.
    Rigo, R.
    Cheung, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S70 - S70
  • [8] A STRATEGY FOR INCREASING CLINICAL TRIAL DIVERSITY USING REAL-WORLD DATA TO INFORM PATIENT SELECTION CRITERIA
    Kargbo, I. M.
    Jin, H.
    Winer-Jones, J.
    VALUE IN HEALTH, 2022, 25 (07) : S607 - S607
  • [9] Mapping Real-World Rheumatoid Arthritis Patients to Clinical Trial Eligibility Criteria
    Keystone, Edward
    Olszynski, Wojciech
    Bessette, Louis
    Rahman, Proton
    Rampakakis, Emmanouil
    Lehman, Allen
    Asin-Milan, Odalis
    Nantel, Francois
    Rachich, Meagan
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1107 - 1108
  • [10] Mapping Real-World Ankylosing Spondylitis Patients to Clinical Trial Eligibility Criteria
    Sholter, Dalton
    Inman, Robert
    Masetto, Ariel
    Rahman, Proton
    Rampakakis, Emmanouil
    Asin-Milan, Odalis
    Rachich, Meagan
    Nantel, Francois
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1101 - 1101
12345